Sangamo Therapeutics, Inc. (SGMO)
NASDAQ: SGMO · IEX Real-Time Price · USD
0.561
+0.038 (7.26%)
At close: May 10, 2024, 4:00 PM
0.560
-0.001 (-0.25%)
After-hours: May 10, 2024, 7:54 PM EDT
Sangamo Therapeutics Stock Forecast
SGMO's stock price has decreased by -55.8% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 6 analysts with 12-month price forecasts for SGMO stock have an average target of 5.17, with a low estimate of 1.00 and a high estimate of 10. The average target predicts an increase of 820.91% from the current stock price of 0.56.
Analyst Consensus: Buy
* Price targets were last updated on Mar 19, 2024.
Analyst Ratings
The average analyst rating for SGMO stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 → $5 | Strong Buy | Reiterates | $3 → $5 | +790.63% | Mar 19, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $2 | Hold | Reiterates | $2 | +256.25% | Mar 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3 | Strong Buy | Maintains | $3 | +434.38% | Mar 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +434.38% | Feb 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +434.38% | Feb 6, 2024 |
Financial Forecast
Revenue This Year
46.80M
from 176.23M
Decreased by -73.45%
Revenue Next Year
80.59M
from 46.80M
Increased by 72.21%
EPS This Year
-0.51
from -1.48
EPS Next Year
-0.28
from -0.51
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 99.8M | 240.5M | 161.7M | 274.1M | 619.6M |
| Avg | 46.8M | 80.6M | 99.5M | 167.9M | 317.4M |
| Low | 13.5M | 25.9M | 51.2M | 43.0M | 134.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -43.4% | 413.8% | 100.6% | 175.4% | 269.1% |
| Avg | -73.4% | 72.2% | 23.5% | 68.7% | 89.1% |
| Low | -92.3% | -44.7% | -36.4% | -56.8% | -19.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.24 | 0.29 | 0.02 | -0.02 | 0.76 |
| Avg | -0.51 | -0.28 | -0.27 | -0.23 | 0.32 |
| Low | -0.75 | -0.63 | -0.60 | -0.43 | -0.10 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.